Aspira Pathlab & Diagnostics Ltd - 540788 - Appointment Of Company Secretary And Compliance Officer Of Company
Appointment of Company Secretary and Compliance Officer of Company13-11-2021
13-11-2021
Aspira Pathlab & Diagnostics Ltd - 540788 - Outcome Of Board Meeting Held On November 13, 2021
Outcome of Board Meeting held on November 13, 202113-11-2021
Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Outcome for Unaudited Financial Results For Quarter Ended September 30, 2021
Unaudited Financial Results for quarter ended September 30, 202113-11-2021
Aspira Pathlab & Diagnostics Ltd - 540788 - Results-Unaudited Financial Results For Quarter Ended September 30, 2021
Results-Unaudited Financial Results for quarter ended September 30, 202113-11-2021
Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter Ended September 30, 2021
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 ,inter alia, to consider and approve the un-audited financial results of the Company for the quarter ended September 30, 202106-11-2021
Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby submit a copy of certificate received from Link Intime (India) Private Limited, Registrar and Share Transfer Agent of the Company, certifying that for the quarter ended September 30, 2021.16-10-2021
Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholding for the Period Ended September 30, 2021
Aspira Pathlab & Diagnostics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here12-10-2021
Aspira Pathlab & Diagnostics Ltd - 540788 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Pankaj ShahDesignation :- Managing Director / Whole Time Director11-10-2021
Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window
This is to inform you that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the code of Prohibition of Insider Trading adopted by Company, the trading window for dealing in securities of the company will remain closed from Friday, 1st October, 2021, till 48 hours after declaration of Unaudited Financial Results of the Company for the Quarter ended 30th September, 2021.30-09-2021
Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Aspira Pathlab & Diagnostics Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here24-09-2021